Ameriprise Financial Inc. Boosts Stock Position in Arcosa, Inc. (NYSE:ACA)

Ameriprise Financial Inc. increased its position in shares of Arcosa, Inc. (NYSE:ACA - Free Report) by 45.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 183,044 shares of the company's stock after purchasing an additional 57,457 shares during the quarter. Ameriprise Financial Inc. owned approximately 0.38% of Arcosa worth $17,711,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently added to or reduced their stakes in ACA. Ancora Advisors LLC grew its stake in Arcosa by 0.7% during the 4th quarter. Ancora Advisors LLC now owns 117,170 shares of the company's stock valued at $11,335,000 after acquiring an additional 826 shares in the last quarter. Aptus Capital Advisors LLC grew its position in shares of Arcosa by 22.1% in the fourth quarter. Aptus Capital Advisors LLC now owns 91,522 shares of the company's stock valued at $8,854,000 after purchasing an additional 16,546 shares in the last quarter. AYAL Capital Advisors Ltd grew its position in shares of Arcosa by 6.2% in the fourth quarter. AYAL Capital Advisors Ltd now owns 86,961 shares of the company's stock valued at $8,413,000 after purchasing an additional 5,100 shares in the last quarter. 4D Advisors LLC acquired a new stake in shares of Arcosa in the fourth quarter valued at approximately $2,418,000. Finally, Mercer Global Advisors Inc. ADV purchased a new position in Arcosa during the fourth quarter worth approximately $473,000. 90.66% of the stock is owned by institutional investors and hedge funds.

Arcosa Trading Down 1.1%

NYSE ACA traded down $0.94 on Thursday, reaching $84.27. 10,834 shares of the company were exchanged, compared to its average volume of 269,460. The company has a current ratio of 3.61, a quick ratio of 2.77 and a debt-to-equity ratio of 0.51. The business's fifty day moving average price is $80.70 and its 200 day moving average price is $92.62. The stock has a market capitalization of $4.11 billion, a P/E ratio of 32.06 and a beta of 1.00. Arcosa, Inc. has a fifty-two week low of $68.11 and a fifty-two week high of $113.43.

Arcosa (NYSE:ACA - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.29 by $0.20. Arcosa had a return on equity of 6.64% and a net margin of 5.17%. The business had revenue of $632.00 million for the quarter, compared to analyst estimates of $613.95 million. During the same quarter in the previous year, the firm earned $0.73 EPS. The company's quarterly revenue was up 5.6% compared to the same quarter last year. Analysts forecast that Arcosa, Inc. will post 3.23 earnings per share for the current year.

Arcosa Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Tuesday, July 15th will be issued a $0.05 dividend. The ex-dividend date is Tuesday, July 15th. This represents a $0.20 annualized dividend and a yield of 0.24%. Arcosa's payout ratio is 12.58%.

Insider Buying and Selling at Arcosa

In other Arcosa news, VP Eric D. Hurst sold 835 shares of Arcosa stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $88.57, for a total value of $73,955.95. Following the sale, the vice president now owns 4,112 shares in the company, valued at $364,199.84. The trade was a 16.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is currently owned by company insiders.

Arcosa Profile

Arcosa, Inc, together with its subsidiaries, provides infrastructure-related products and solutions for the construction, engineered structures, and transportation markets in the United States. It operates through three segments: Construction Products, Engineered Structures, and Transportation Products.